Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nrc Health (NRC) Treasury Shares (2016 - 2026)

Nrc Health's Treasury Shares history spans 16 years, with the latest figure at $152.6 million for Q4 2025.

  • On a quarterly basis, Treasury Shares rose 15.68% to $152.6 million in Q4 2025 year-over-year; TTM through Dec 2025 was $152.6 million, a 15.68% increase, with the full-year FY2025 number at $152.6 million, up 15.68% from a year prior.
  • Treasury Shares hit $9.3 million in Q4 2025 for Nrc Health, roughly flat from $9.3 million in the prior quarter.
  • Over the last five years, Treasury Shares for NRC hit a ceiling of $9.3 million in Q4 2025 and a floor of $12698.0 in Q1 2021.
  • Historically, Treasury Shares has averaged $3.9 million across 5 years, with a median of $3.1 million in 2021.
  • Biggest five-year swings in Treasury Shares: skyrocketed 69.01% in 2022 and later rose 8.48% in 2023.
  • Tracing NRC's Treasury Shares over 5 years: stood at $50.1 million in 2021, then surged by 56.07% to $78.3 million in 2022, then increased by 26.18% to $98.8 million in 2023, then soared by 33.59% to $131.9 million in 2024, then rose by 15.68% to $152.6 million in 2025.
  • Business Quant data shows Treasury Shares for NRC at $152.6 million in Q4 2025, $152.0 million in Q3 2025, and $142.7 million in Q2 2025.